title: DNase is a prognostic marker in liver cancer patients receiving transarterial chemoembolization therapy.
authors.affiliation: Institute of Clinical Chemistry, University-Hospital Munich-Grosshadern, Munich, Germany.
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Kohles
authors.forename: Dorothea
authors.initials: D
authors.lastname: Nagel
authors.forename: Dietrich
authors.initials: D
authors.lastname: Jüngst
authors.forename: Petra
authors.initials: P
authors.lastname: Stieber
authors.forename: Stefan
authors.initials: S
authors.lastname: Holdenrieder
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D003851:Deoxyribonucleases / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D024243:HMGB1 Protein / Q000097:blood; D006801:Humans; D053208:Kaplan-Meier Estimate; D008113:Liver Neoplasms / Q000097:blood* / Q000628:therapy*; D008297:Male; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D024243:HMGB1 Protein; D003851:Deoxyribonucleases